Compare Medicalgorithmics SA with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Poor long term growth as Net Sales has grown by an annual rate of -26.13% and Operating profit at 9.04% over the last 5 years
3
The company has declared Negative results for the last 6 consecutive quarters
4
Risky -
Stock DNA
Pharmaceuticals & Biotechnology
PLN 326 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.25
-23.34%
4.95
Revenue and Profits:
Net Sales:
7 Million
(Quarterly Results - Mar 2025)
Net Profit:
-4 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
15.9%
0%
15.9%
6 Months
78.71%
0%
78.71%
1 Year
20.96%
0%
20.96%
2 Years
59.95%
0%
59.95%
3 Years
446.77%
0%
446.77%
4 Years
0.63%
0%
0.63%
5 Years
46.14%
0%
46.14%
Medicalgorithmics SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-26.13%
EBIT Growth (5y)
9.04%
EBIT to Interest (avg)
-17.34
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
0.38
Tax Ratio
1.91%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.26%
ROCE (avg)
0.27%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.85
EV to EBIT
-20.83
EV to EBITDA
-23.65
EV to Capital Employed
4.25
EV to Sales
14.13
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-20.41%
ROE (Latest)
-19.29%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Mar 2020
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.26%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
Mar'25
Dec'24
Change(%)
Net Sales
6.80
5.90
15.25%
Operating Profit (PBDIT) excl Other Income
-3.60
-4.90
26.53%
Interest
0.30
0.10
200.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-4.20
-4.60
8.70%
Operating Profit Margin (Excl OI)
-671.30%
-891.90%
22.06%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2025 is 15.25% vs 13.46% in Dec 2024
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2025 is 8.70% vs -119.05% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
24.00
43.10
-44.32%
Operating Profit (PBDIT) excl Other Income
-16.80
2.50
-772.00%
Interest
0.20
0.10
100.00%
Exceptional Items
0.00
0.70
-100.00%
Consolidate Net Profit
-16.10
-0.60
-2,583.33%
Operating Profit Margin (Excl OI)
-852.60%
3.20%
-85.58%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -44.32% vs -31.26% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -2,583.33% vs -102.35% in Dec 2023
About Medicalgorithmics SA 
Medicalgorithmics SA
Pharmaceuticals & Biotechnology
Medicalgorithmics SA is a Poland-based company engaged in the advanced medical equipment and technology industry. The Company develops and manufactures system for the diagnosis of heart arrhythmia. Its product, named PocketECG, is used for remote monitoring of cardiac disorders, arrhythmia diagnosis and monitoring of heart, as well as is used for clinical drugs trials for cardiac safety. In addition, Medicalgorithmics SA provides services in the field of information technology and biotechnology, scientific research and development of natural sciences. Moreover, the Company works on the several projects, such as a device for tele-rehabilitation cardiology, software for optimizing repetitive task in hospitals, as well as devices and systems for remote description of the electrocardiography (ECG). It operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC and Medi-Lynx Cardiac Monitoring LLC.
Company Coordinates 
Company Details
Al. Jerozolimskie 81 , WARSZAWA None : 02-001
Registrar Details






